Luye Pharma Group (P Dividend yield

 Price  4.07
 Dividend  0.00
 Earnings  0.30
 Cash-flow  0.39
 Book value  2.54
 Equity  2.65

Luye Pharma Group (P is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Luye Pharma Group (P is a company from China, and his stocks are publicly traded.

Luye Pharma Group (P paid a total dividend of 0 million HKD last year, for a market value of 14,412 millions (Market Cap 7,181 millions). Dividend per share of Luye Pharma Group (P is 0.00 HKD, and his stock market price 4.07 HKD.

According to the chart below where dividend yield is displayed, Luye Pharma Group (P, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from China, Health Care industry, and Pharmaceuticals and Biotechnology sector. This lack of dividends of Luye Pharma Group (P might harm the evolution of share price if the company is not clearly expanding his business.

In addition, you should compare Luye Pharma Group (P dividend yield with other Pharmaceuticals and Biotechnology companies or firms from China.

Dividend yield of Luye Pharma Group (P

Luye Pharma Group (P Dividend Payout

About the ability of Luye Pharma Group (P to maintain his current dividend of HKD 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Luye Pharma Group (P payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.

The following figure shows payout ratios over earnings and cashflow of Luye Pharma Group (P, compared againt world market average, China companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Luye Pharma Group (P payout

Luye Pharma Group (P Dividend History

Year Yield  HKD  Paypout  Shares* 

*In millions

Luye Pharma Group (P Stock performance

Finally, last moth Luye Pharma Group (P showed a return of -1.90% compared to a worldwide -1.33% average, and a -3.33% of Health Care firms. Over the last year, the company obtained a -9.60% versus a worldwide performance of a 31.58%. More detailed information can be seen in the following graph for China and Pharmaceuticals and Biotechnology firms.

Luye Pharma Group (P stock and market return